• Biopolitics With Allan Shaw

  • Nov 25 2024
  • Length: 50 mins
  • Podcast

Biopolitics With Allan Shaw

  • Summary

  • We love to hear from our listeners. Send us a message.

    The notion that political influence has no place in biology appears poised for a test it hasn’t studied for. Trump administration nominations, from RFK, Jr. to HHS and Vivek Ramaswamy to the newly-proposed DOGE, are driving a storm of speculation over the implications for biotech and other life sciences industries. Throw in the increased probability of the Biosecure Act seeing the light of legislation day under a republican congress, and there’s no shortage of biopolitical pontificating to be done. How might this all play out, and how should biotech builders be obviating? On this episode of the Business of Biotech, we’re joined for some reflection by none other than Allan Shaw.

    Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.

    Subscribe to our monthly Business of Biotech newsletter.

    Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.com

    Find Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/


    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Biopolitics With Allan Shaw

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.